Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Immunosuppression in tumor immune microenvironment and its optimization from CAR-T cell therapy
Zaoqu Liu, Zhaokai Zhou, Qin Dang, et al.
Theranostics (2022) Vol. 12, Iss. 14, pp. 6273-6290
Open Access | Times Cited: 86

Showing 1-25 of 86 citing articles:

CAR-cell therapy in the era of solid tumor treatment: current challenges and emerging therapeutic advances
Karama Makni‐Maalej, Maysaloun Merhi, Varghese Inchakalody, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 289
Notch signaling pathway in cancer: from mechanistic insights to targeted therapies
Qingmiao Shi, Chen Xue, Yifan Zeng, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 84
Immunologic tumor microenvironment modulators for turning cold tumors hot
Gholamreza Khosravi, Samaneh Mostafavi, Sanaz Bastan, et al.
Cancer Communications (2024) Vol. 44, Iss. 5, pp. 521-553
Open Access | Times Cited: 61
Recent Advances in CAR-Based Solid Tumor Immunotherapy
Min Hwa Shin, Eunha Oh, Yun Jeong Kim, et al.
Cells (2023) Vol. 12, Iss. 12, pp. 1606-1606
Open Access | Times Cited: 43
Current challenges and therapeutic advances of CAR-T cell therapy for solid tumors
T. R. Chen, Mingzhao Wang, Yanchao Chen, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 32
Advancements in CAR-NK therapy: lessons to be learned from CAR-T therapy
Marisa K. Kilgour, Donald Bastin, Seung‐Hwan Lee, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 39
Deciphering the tumor immune microenvironment from a multidimensional omics perspective: insight into next-generation CAR-T cell immunotherapy and beyond
Zhaokai Zhou, Jiahui Wang, Jiaojiao Wang, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 15
Advancements and challenges in developing in vivo CAR T cell therapies for cancer treatment
Thuỳ Anh Bùi, Haoqi Mei, Rui Sang, et al.
EBioMedicine (2024) Vol. 106, pp. 105266-105266
Open Access | Times Cited: 15
The potential and promise for clinical application of adoptive T cell therapy in cancer
Yinqi Li, Yeteng Zheng, Taiqing Liu, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 12
Emerging role of immunogenic cell death in cancer immunotherapy: Advancing next-generation CAR-T cell immunotherapy by combination
Zhaokai Zhou, Yumiao Mai, Ge Zhang, et al.
Cancer Letters (2024) Vol. 598, pp. 217079-217079
Closed Access | Times Cited: 12
The underlying mechanism of chimeric antigen receptor (CAR)-T cell therapy triggering secondary T-cell cancers: Mystery of the Sphinx?
Zhaokai Zhou, Ge Zhang, Yudi Xu, et al.
Cancer Letters (2024) Vol. 597, pp. 217083-217083
Closed Access | Times Cited: 10
Recent advances in targeted drug delivery for the treatment of glioblastoma
Meng Mao, Yingjie Wu, Qiang He
Nanoscale (2024) Vol. 16, Iss. 18, pp. 8689-8707
Closed Access | Times Cited: 9
From Crypts to Cancer: A Holistic Perspective on Colorectal Carcinogenesis and Therapeutic Strategies
Ehsan Gharib, Gilles A. Robichaud
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 17, pp. 9463-9463
Open Access | Times Cited: 9
The Histomorphology to Molecular Transition: Exploring the Genomic Landscape of Poorly Differentiated Epithelial Endometrial Cancers
Thulo Molefi, Lloyd Mabonga, Rodney Hull, et al.
Cells (2025) Vol. 14, Iss. 5, pp. 382-382
Open Access | Times Cited: 1
Are monocytes a preferable option to develop myeloid cell-based therapies for solid tumors?
Daisy Bhatia, Riccardo Dolcetti, Roberta Mazzieri
Journal of Experimental & Clinical Cancer Research (2025) Vol. 44, Iss. 1
Open Access | Times Cited: 1
Revolutionizing cancer treatment: a comprehensive review of CAR-T cell therapy
Preeti Dabas, Adithi Danda
Medical Oncology (2023) Vol. 40, Iss. 9
Closed Access | Times Cited: 17
Advancements in Personalized CAR-T Therapy: Comprehensive Overview of Biomarkers and Therapeutic Targets in Hematological Malignancies
Wioletta Olejarz, Karol Sadowski, Daniel Szulczyk, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 14, pp. 7743-7743
Open Access | Times Cited: 7
Exosomes as drug delivery systems in glioma immunotherapy
Xinqing Hao, Shiming Wang, Liang Wang, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 6
Multifunctional nanoparticles inhibit tumor and tumor-associated macrophages for triple-negative breast cancer therapy
Yan Liu, Dan Zhang, Zongquan Zhang, et al.
Journal of Colloid and Interface Science (2023) Vol. 657, pp. 598-610
Closed Access | Times Cited: 16
Nanoparticle Strategies to Improve the Delivery of Anticancer Drugs across the Blood–Brain Barrier to Treat Brain Tumors
Wouter J. F. Vanbilloen, Julian S. Rechberger, Jacob B. Anderson, et al.
Pharmaceutics (2023) Vol. 15, Iss. 7, pp. 1804-1804
Open Access | Times Cited: 15
Navigating the Immune Maze: Pioneering Strategies for Unshackling Cancer Immunotherapy Resistance
Liqin Yao, Qingqing Wang, Wenxue Ma
Cancers (2023) Vol. 15, Iss. 24, pp. 5857-5857
Open Access | Times Cited: 13
Harnessing immunotherapy for brain metastases: insights into tumor–brain microenvironment interactions and emerging treatment modalities
Dairan Zhou, Zhenyu Gong, Dejun Wu, et al.
Journal of Hematology & Oncology (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 13
CAR-macrophage versus CAR-T for solid tumors: The race between a rising star and a superstar
Kun Chen, Minling Liu, Jiancheng Wang, et al.
Biomolecules and Biomedicine (2023) Vol. 24, Iss. 3, pp. 465-476
Open Access | Times Cited: 11
BCKDK modification enhances the anticancer efficacy of CAR-T cells by reprogramming branched chain amino acid metabolism
Quanjun Yang, Xinting Zhu, Ping Huang, et al.
Molecular Therapy (2024) Vol. 32, Iss. 9, pp. 3128-3144
Open Access | Times Cited: 4
CAR-T cell therapy in advanced thyroid cancer: from basic to clinical
Zhenhua Sun, Chaohui Wang, Yuyang Zhao, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top